Sign In
Buy GLUE
$23.04
-1.48 (-6.04%)
At Close: Jul 10, 2026
Monte Rosa Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Pipeline and Business Progress
07:30am, Thursday, 12'th Aug 2021
– Completed upsized $255.6 million IPO; cash runway extended into late 2024
6 Companies Are Making Their Trading Debuts. What Investors Need to Know.
12:15pm, Thursday, 24'th Jun 2021
The IPO tidal wave continued Thursday, with a mix of healthcare and technology startups making their trading debut.
Monte Rosa Therapeutics Announces Pricing of Initial Public Offering
08:20pm, Wednesday, 23'rd Jun 2021
BOSTON, June 23, 2021 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE), a biotechnology company developing a portfolio of novel small molecule precision medicines that employ the body'
